Долгий ковид у привитых
Long COVID in a highly vaccinated population infected during a SARS-CoV-2 Omicron wave - Australia, 2022
Исследованиев Австралии на примерно 12 тыс участников с 3+ прививками от ковида, подхвативших омикрон в прошлом году во время омикроновой волны (не смотря на высокую привитость), показало, что примерно каждый пятый после омикрона остался с "долгим ковидом" в течении 3 мес после диагноза. Среднее количество постковидных симптомов было 6, доминировали "хроническая усталость" и проблемы с концентрацией внимания, около 40% вынуждены были обращаться с постковидными симптомами к доктору, и около 1.5% госпитализировались. Примерно 17% "долгоковидных" из-за постковидных симптомов не смогли работать учиться и пр " как раньше", по состоянию здоровья.
[Spoiler (click to open)]Objective: To characterise Long COVID in a highly vaccinated population infected by Omicron. Design: Follow-up survey of persons testing positive for SARS-CoV-2 in Western Australia, 16 July-3 August 2022. Setting: Community Participants: 22,744 persons with COVID-19 who had agreed to participate in research at the time of diagnosis were texted a survey link 90 days later; non-responders were telephoned. Post stratification weights were applied to responses from 11,697 (51.4%) participants, 94.0% of whom had received >= 3 vaccine doses. Main outcome measures: Prevalence of Long COVID - defined as reporting new or ongoing COVID-19 illness-related symptoms or health issues 90 days post diagnosis; associated health care utilisation, reductions in work/study and risk factors were assessed using log-binomial regression. Results: 18.2% (n=2,130) of respondents met case definition for Long COVID. Female sex, being 50-69 years of age, pre-existing health issues, residing in a rural or remote area, and receiving fewer vaccine doses were significant independent predictors of Long COVID (p < 0.05). Persons with Long COVID reported a median of 6 symptoms, most commonly fatigue (70.6%) and difficulty concentrating (59.6%); 38.2% consulted a GP and 1.6% reported hospitalisation in the month prior to the survey due to ongoing symptoms. Of 1,778 respondents with Long COVID who were working/studying before their COVID-19 diagnosis, 17.9% reported reducing/discontinuing work/study. Conclusion: 90 days post Omicron infection, almost 1 in 5 respondents reported Long COVID symptoms; 1 in 15 of all persons with COVID-19 sought healthcare for associated health concerns >=2 months after the acute illness.
Исследованиев Австралии на примерно 12 тыс участников с 3+ прививками от ковида, подхвативших омикрон в прошлом году во время омикроновой волны (не смотря на высокую привитость), показало, что примерно каждый пятый после омикрона остался с "долгим ковидом" в течении 3 мес после диагноза. Среднее количество постковидных симптомов было 6, доминировали "хроническая усталость" и проблемы с концентрацией внимания, около 40% вынуждены были обращаться с постковидными симптомами к доктору, и около 1.5% госпитализировались. Примерно 17% "долгоковидных" из-за постковидных симптомов не смогли работать учиться и пр " как раньше", по состоянию здоровья.
[Spoiler (click to open)]Objective: To characterise Long COVID in a highly vaccinated population infected by Omicron. Design: Follow-up survey of persons testing positive for SARS-CoV-2 in Western Australia, 16 July-3 August 2022. Setting: Community Participants: 22,744 persons with COVID-19 who had agreed to participate in research at the time of diagnosis were texted a survey link 90 days later; non-responders were telephoned. Post stratification weights were applied to responses from 11,697 (51.4%) participants, 94.0% of whom had received >= 3 vaccine doses. Main outcome measures: Prevalence of Long COVID - defined as reporting new or ongoing COVID-19 illness-related symptoms or health issues 90 days post diagnosis; associated health care utilisation, reductions in work/study and risk factors were assessed using log-binomial regression. Results: 18.2% (n=2,130) of respondents met case definition for Long COVID. Female sex, being 50-69 years of age, pre-existing health issues, residing in a rural or remote area, and receiving fewer vaccine doses were significant independent predictors of Long COVID (p < 0.05). Persons with Long COVID reported a median of 6 symptoms, most commonly fatigue (70.6%) and difficulty concentrating (59.6%); 38.2% consulted a GP and 1.6% reported hospitalisation in the month prior to the survey due to ongoing symptoms. Of 1,778 respondents with Long COVID who were working/studying before their COVID-19 diagnosis, 17.9% reported reducing/discontinuing work/study. Conclusion: 90 days post Omicron infection, almost 1 in 5 respondents reported Long COVID symptoms; 1 in 15 of all persons with COVID-19 sought healthcare for associated health concerns >=2 months after the acute illness.